Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study

Polycythemia vera (PV) is associated with increased risk of thrombosis and hemorrhage. Aspirin, recommended for primary thromboprophylaxis, is often combined with anticoagulants during management of acute thrombotic events. The safety of dual antiplatelet and anticoagulant therapy is not established...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwicker, Jeffrey I., Paranagama, Dilan, Lessen, David S., Colucci, Philomena M., Grunwald, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052904/
https://www.ncbi.nlm.nih.gov/pubmed/34162181
http://dx.doi.org/10.3324/haematol.2021.279032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052904/
https://www.ncbi.nlm.nih.gov/pubmed/34162181
http://dx.doi.org/10.3324/haematol.2021.279032

Ejemplares similares